Published in N Engl J Med on December 05, 2002
Atrial Fibrillation, Cardiac Symptoms, and Anxiety | NCT02133365
Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation | NCT00224341
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . J Am Coll Cardiol (2013) 2.76
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52
Atrial fibrillation: established and innovative methods of evaluation and treatment. Dtsch Arztebl Int (2012) 2.43
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace (2010) 2.12
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Circulation (2015) 2.12
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol (2007) 1.79
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation (2012) 1.67
Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur J Clin Pharmacol (2008) 1.61
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol (2011) 1.58
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial). J Cardiovasc Electrophysiol (2010) 1.57
Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace (2010) 1.47
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart (2007) 1.44
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace (2010) 1.43
Role of the simultaneous sequential strategy for failed acute sinus restoration after modified left maze procedure for persistent atrial fibrillation with concomitant mitral surgery. World J Surg (2006) 1.40
Update on anti-coagulation in atrial fibrillation. QJM (2011) 1.28
New developments in atrial antiarrhythmic drug therapy. Nat Rev Cardiol (2010) 1.27
Cardioversion in Non-Valvular Atrial Fibrillation. Dtsch Arztebl Int (2015) 1.18
Management of atrial fibrillation--what are the possibilities of early detection with home monitoring? Clin Res Cardiol (2006) 1.17
A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation. Ann Emerg Med (2010) 1.15
Rate control in the medical management of atrial fibrillation. Heart (2006) 1.13
Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol (2013) 1.11
Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm control. BMJ (2003) 1.11
Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 1.09
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Treatment strategy and clinical outcome in Japanese patients with atrial fibrillation. Heart Vessels (2009) 1.03
Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat. Br J Clin Pharmacol (2005) 1.03
Planning and monitoring of patients for electrical cardioversion for atrial fibrillation. Neth Heart J (2012) 0.99
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc Health Risk Manag (2011) 0.99
Current and future concepts in stroke prevention. CMAJ (2004) 0.99
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg (2014) 0.99
European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. Eur J Prev Cardiol (2015) 0.99
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J (2009) 0.96
Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. J Cardiothorac Surg (2012) 0.95
Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Heart (2006) 0.93
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc (2009) 0.93
Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol (2005) 0.93
Surgical Outcomes of Cox-maze IV Procedure Using Bipolar Irrigated Radiofrequency Ablation and Cryothermy in Valvular Heart Disease. Korean J Thorac Cardiovasc Surg (2011) 0.93
Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med (2014) 0.92
Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 0.92
Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study. Heart (2005) 0.91
[Atrial fibrillation: rate or rhythm control--individual patient management]. Z Kardiol (2005) 0.89
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation. Drug Des Devel Ther (2011) 0.89
Cardiology. Br J Gen Pract (2004) 0.89
Simplified cardioversion service with intravenous midazolam. Heart (2004) 0.88
Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study. Neth Heart J (2011) 0.88
The surgical treatment of atrial fibrillation. Surg Clin North Am (2009) 0.88
Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. Am J Med (2013) 0.87
Role of oral anticoagulation in management of atrial fibrillation. Heart (2004) 0.87
Cardiac metabolism and arrhythmias. Circ Arrhythm Electrophysiol (2009) 0.87
[Current role of amiodarone in antiarrhythmic therapy]. Herzschrittmacherther Elektrophysiol (2010) 0.87
Minimally invasive surgical therapies for atrial fibrillation. ISRN Cardiol (2012) 0.87
Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace (2011) 0.87
Evaluation of the Pulmonary Veins and Left Atrial Volume using Multidetector Computed Tomography in Patients Undergoing Catheter Ablation for Atrial Fibrillation. Curr Cardiol Rev (2009) 0.86
Rate versus rhythm control in atrial fibrillation. Can Fam Physician (2013) 0.86
Rhythm versus rate control for atrial fibrillation management: what recent randomized clinical trials allow us to affirm. CMAJ (2003) 0.86
Targets and endpoints in ablation therapy for atrial fibrillation in the light of pathophysiological mechanisms. J Interv Card Electrophysiol (2006) 0.86
Rate control management of atrial fibrillation: may a mathematical model suggest an ideal heart rate? PLoS One (2015) 0.85
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol (2008) 0.85
Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation. J Interv Card Electrophysiol (2007) 0.85
Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide. Neth Heart J (2015) 0.85
Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital. Heart (2004) 0.85
Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study. Clin Res Cardiol (2011) 0.85
Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation. Circulation (2016) 0.85
Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system. Int Arch Med (2009) 0.84
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail (2012) 0.84
Cryoablation of atrial fibrillation. J Interv Card Electrophysiol (2011) 0.84
Atrial fibrillation: effects beyond the atrium? Cardiovasc Res (2015) 0.84
Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacol Ther (2011) 0.83
Management of atrial fibrillation. Vasc Health Risk Manag (2007) 0.83
Atrial fibrillation--rhythm or rate control. N Engl J Med (2002) 0.83
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation. BMC Cardiovasc Disord (2005) 0.83
Atrial fibrillation and heart failure in the elderly. Heart Fail Rev (2012) 0.83
[New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers]. Herzschrittmacherther Elektrophysiol (2006) 0.83
Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol (2012) 0.83
[Anticoagulation with atrial fibrillation]. Herzschrittmacherther Elektrophysiol (2006) 0.82
Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. JACC Clin Electrophysiol (2015) 0.82
Short-term ECG recordings for heart rate assessment in patients with chronic atrial fibrillation. Arch Med Sci (2014) 0.82
Internal defibrillation: where we have been and where we should be going? J Interv Card Electrophysiol (2005) 0.82
Cost of atrial fibrillation: invasive vs non-invasive management in 2012. Curr Cardiol Rev (2012) 0.82
Novel anti-arrhythmic medications in the treatment of atrial fibrillation. Curr Cardiol Rev (2012) 0.82
Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation. J Physiol (2011) 0.82
Catheter and surgical ablation of atrial fibrillation. Heart (2006) 0.82
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control. Crit Care (2004) 0.82
Effects of ventricular rate and regularity on the velocity and magnitude of left atrial appendage flow in atrial fibrillation. Heart (2005) 0.82
[Atrial fibrillation, frequency, etiologic factors, evolution and treatment in a cardiology department in Dakar, Senegal]. Pan Afr Med J (2010) 0.81
Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med (2007) 0.81
Can we improve outcomes in AF patients by early therapy? BMC Med (2009) 0.81
Prediction and personalised treatment of atrial fibrillation-stroke prevention: consolidated position paper of CVD professionals. EPMA J (2014) 0.81
[Electrical and pharmacological strategies for early cardioversion of atrial fibrillation]. Herzschrittmacherther Elektrophysiol (2006) 0.81
Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable? Heart Vessels (2006) 0.80
Randomized trials of rate vs. rhythm control for atrial fibrillation. J Interv Card Electrophysiol (2004) 0.80
The WATCHMAN left atrial appendage closure device for atrial fibrillation. J Vis Exp (2012) 0.80
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Frequency analysis of atrial fibrillation from the surface electrocardiogram. Indian Pacing Electrophysiol J (2004) 0.80
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med (2002) 8.72
Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med (2009) 8.51
Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med (2010) 8.17
Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med (2005) 7.80
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med (2004) 6.00
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med (2007) 5.78
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46
Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry (2007) 4.44
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med (2002) 4.33
Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation (2010) 3.98
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol (2013) 3.54
Corticosteroids and the risk of atrial fibrillation. Arch Intern Med (2006) 3.28
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J (2009) 3.06
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation (2004) 3.05
Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation (2008) 2.96
Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: adenosine-free assessment of functional coronary lesion severity. Circ Cardiovasc Interv (2012) 2.93
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93
Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation (2007) 2.90
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J (2010) 2.86
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) (2004) 2.81
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria. EuroIntervention (2016) 2.67
Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol (2010) 2.59
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol (2010) 2.50
Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest (2005) 2.50
Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J (2004) 2.44
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med (2006) 2.42
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res (2009) 2.41
Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry (2006) 2.41
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res (2004) 2.31
Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J (2005) 2.28
Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation (2003) 2.28
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med (2008) 2.23
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J (2011) 2.21
Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study. J Am Coll Cardiol (2011) 2.19
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease. J Am Coll Cardiol (2002) 2.18
Who is at risk of post-MI depressive symptoms? J Psychosom Res (2005) 2.18
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol (2010) 2.17
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol (2009) 2.16
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol (2004) 2.10
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. JAMA (2008) 2.09
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation). J Am Coll Cardiol (2013) 2.08
Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement. Clin Chem (2004) 2.08
Impact of onsite or dispatched automated external defibrillator use on survival after out-of-hospital cardiac arrest. Circulation (2011) 2.01
General anesthesia with sevoflurane decreases myocardial blood volume and hyperemic blood flow in healthy humans. Anesth Analg (2013) 2.01
Importance of the first link: description and recognition of an out-of-hospital cardiac arrest in an emergency call. Circulation (2009) 2.00
The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr (2007) 1.95
Relation of levels of serum lipoproteins to depression after acute myocardial infarction. Am J Cardiol (2002) 1.92
Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the Netherlands. J Am Coll Cardiol (2011) 1.92
Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm (2006) 1.91
5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol (2010) 1.91
Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J (2009) 1.90
Automatic segmentation of echocardiographic sequences by active appearance motion models. IEEE Trans Med Imaging (2002) 1.88
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol (2009) 1.87
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84
Antipsychotics and the risk of sudden cardiac death. Arch Intern Med (2004) 1.78
Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes. Gen Hosp Psychiatry (2005) 1.76
Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J (2004) 1.74
Implantable cardioverter-defibrillators have reduced the incidence of resuscitation for out-of-hospital cardiac arrest caused by lethal arrhythmias. Circulation (2012) 1.73
Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol (2006) 1.73
Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia). J Cardiovasc Electrophysiol (2002) 1.72
Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol (2005) 1.71
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J (2005) 1.71
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace (2008) 1.68
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol (2011) 1.68
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace (2012) 1.67
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64
International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med (2015) 1.64
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol (2006) 1.63
Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol (2006) 1.63
Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J (2003) 1.63
Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes. Heart (2009) 1.62
Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. Europace (2011) 1.61
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J (2011) 1.60
The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace (2010) 1.59
Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol (2008) 1.58
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Catheter Cardiovasc Interv (2008) 1.58
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace (2011) 1.57
Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate. J Cardiovasc Electrophysiol (2004) 1.57
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J (2008) 1.57